Guided Therapeutics (GTHP) Equity Average (2012 - 2025)
Guided Therapeutics recorded quarterly Equity Average of -$5.8 million in Q4 2025, down 4.73% quarter-over-quarter from -$5.6 million in Q3 2025, and down 19.3% year-over-year from -$7.2 million in Q4 2024.
Guided Therapeutics' Equity Average history runs 14 years deep, the most recent figure standing at -$5.8 million for Q4 2025.
- In Q4 2025, Equity Average fell 19.3% year-over-year to -$5.8 million; the TTM figure through Dec 2025 stood at -$5.8 million (down 19.3% YoY), while the FY2025 annual figure was -$5.4 million, down 25.23% from the prior year.
- Equity Average came in at -$5.8 million for Q4 2025 at Guided Therapeutics, down from -$5.6 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of -$2.8 million in Q4 2022 to a low of -$9.4 million in Q1 2021.
- A 5-year average of -$5.1 million and a median of -$4.9 million in 2024 frame the typical range for Equity Average.
- Across the five-year window, Equity Average jumped 58.05% in 2022 and plunged 40.66% in 2024, its largest moves.
- Guided Therapeutics' Equity Average stood at -$6.6 million in 2021, then surged by 58.05% to -$2.8 million in 2022, then plunged by 34.73% to -$3.7 million in 2023, then tumbled by 31.53% to -$4.9 million in 2024, then slipped by 19.3% to -$5.8 million in 2025.
- According to Business Quant data, Equity Average over the past three periods registered -$5.8 million, -$5.6 million, and -$5.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -5.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.85 Mn |
| Sep 30, 2025 | -5.59 Mn |
| Jun 30, 2025 | -5.25 Mn |
| Mar 31, 2025 | -4.96 Mn |
| Dec 31, 2024 | -4.90 Mn |
| Sep 30, 2024 | -4.79 Mn |
| Jun 30, 2024 | -4.34 Mn |
| Mar 31, 2024 | -3.91 Mn |
| Dec 31, 2023 | -3.73 Mn |
| Sep 30, 2023 | -3.48 Mn |
| Jun 30, 2023 | -3.09 Mn |
| Mar 31, 2023 | -2.87 Mn |
| Dec 31, 2022 | -2.77 Mn |
| Sep 30, 2022 | -4.21 Mn |
| Jun 30, 2022 | -5.38 Mn |
| Mar 31, 2022 | -5.22 Mn |
| Dec 31, 2021 | -6.60 Mn |
| Sep 30, 2021 | -7.87 Mn |
| Jun 30, 2021 | -7.99 Mn |
| Mar 31, 2021 | -9.42 Mn |
| Dec 31, 2020 | -12.34 Mn |
| Sep 30, 2020 | -15.12 Mn |
| Jun 30, 2020 | -13.88 Mn |
| Mar 31, 2020 | -14.14 Mn |
| Dec 31, 2019 | -17.48 Mn |
| Sep 30, 2019 | -18.30 Mn |
| Jun 30, 2019 | -17.30 Mn |
| Mar 31, 2019 | -15.92 Mn |
| Dec 31, 2018 | -15.00 Mn |
| Sep 30, 2018 | -14.19 Mn |
| Jun 30, 2018 | -16.08 Mn |
| Mar 31, 2018 | -18.67 Mn |
| Dec 31, 2017 | -15.87 Mn |
| Sep 30, 2017 | -11.35 Mn |
| Jun 30, 2017 | -9.70 Mn |
| Mar 31, 2017 | -9.16 Mn |
| Dec 31, 2016 | -8.29 Mn |
| Sep 30, 2016 | -7.22 Mn |
| Jun 30, 2016 | -6.29 Mn |
| Mar 31, 2016 | -5.51 Mn |
| Dec 31, 2015 | -4.52 Mn |
| Sep 30, 2015 | -3.11 Mn |
| Jun 30, 2015 | -3.88 Mn |
| Mar 31, 2015 | -4.74 Mn |
| Dec 31, 2014 | -4.21 Mn |
| Sep 30, 2014 | -3.22 Mn |
| Jun 30, 2014 | -1.88 Mn |
| Mar 31, 2014 | -688,500.00 |
| Dec 31, 2013 | 207,500.00 |
| Sep 30, 2013 | 1.13 Mn |
| Jun 30, 2013 | 1.80 Mn |
| Mar 31, 2013 | 1.50 Mn |
| Dec 31, 2012 | 1.63 Mn |
| Sep 30, 2012 | 1.28 Mn |
| Jun 30, 2012 | 673,000.00 |
| Mar 31, 2012 | 1.24 Mn |